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INTRODUCTION
Perinatal hypoxic-ischemic brain injury remains a major
cause of neonatal and infant mortality, and of permanent neuro-
developmental sequelae such as mental retardation, seizure
disorders and cerebral palsy (1). Hypoxic-ischemic brain dam-
age is an evolving process, which begins during the primary
hypoxic-ischemic insult and extends into the recovery period
after oxygenation and perfusion have been restored (2). Evi-
dence is accumulating in neonatal brain ischemia models that
the post-ischemic reperfusion period may be of major patho-
genetic importance (3). It has subsequently been confirmed
that ischemia-reperfusion in other species, including rat, leads
to production of free radicals (4). These reactive oxygen species
and their product, lipid peroxides, are thought to be among
the important causes of cell membrane destruction and cell
damage (5, 6).
There have been attempts to eliminate free radicals through
inhibition of xanthine oxidase with allopurinol (7, 8). How-
ever, the results were mostly negative, probably because allo-
purinol does not penetrate well into the brain and because
inhibition of xanthine oxidease there is minor and incom-
plete (9). Free radical scavengers such as superoxide dismu-
tase and catalase have been shown to ameliorate the ischemic
brain damage (10, 11). However, the therapeutic potentials
of these free radical scavengers are limited by circulatory half-
lives of only 6 to 10 min following intravenous injection (12).
Furthermore, partially reduced oxygen species can only dif-
fuse short distance before reacting with cellular components,
and neither superoxide dismutase nor catalase can penetrate
cell membrane to gain access to intracellular sites of free radi-
cal generation (13).
The spin trapping agent,  -phenyl-n-tert-butyl nitrone
(PBN) is a well-recognized tool with which to demonstrate
free radicals. It reacts with reactive oxygen species to form
stable adducts that can be detected, identified, or quantitated
(14, 15). Recently, PBN has been discovered to have a neuro-
protective effect on focal ischemic brain injury. PBN reduced
the infarct size and prevented the secondary energy failure
and mitochondrial dysfunction (16-18). Although the detailed
mechanism of its action is unclear, the neuroprotective effect
of PBN seems to result primarily from efficient scavenging
of oxygen free radicals (19). In addition, PBN has a low tox-
icity, and because of its lipophilicity, this substance readily
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Effects of -Phenyl-N-tert-Butyl Nitrone (PBN) on Brain Cell Membrane
Function and Energy Metabolism during Transient Global Cerebral
Hypoxia-Ischemia and Reoxygenation-Reperfusion in Newborn Piglets
We sought to know whether a free radical spin trap agent,  -phenyl-N-tert-butyl
nitrone (PBN) influences brain cell membrane function and energy metabolism
during and after transient global hypoxia-ischemia (HI) in the newborn piglets.
Cerebral HI was induced by temporary complete occlusion of bilateral common
carotid arteries and simultaneous breathing with 8% oxygen for 30 min, followed
by release of carotid occlusion and normoxic ventilation for 1 hr (reoxygenation-
reperfusion, RR). PBN (100 mg/kg) or vehicle was administered intravenously just
before the induction of HI or RR. Brain cortex was harvested for the biochemical
analyses at the end of HI or RR. The level of conjugated dienes significantly
increased and the activity of Na
+, K
+-ATPase significantly decreased during HI,
and they did not recover during RR. The levels of ATP and phosphocreatine (PCr)
significantly decreased during HI, and recovered during RR. PBN significantly
decreased the level of conjugated dienes both during HI and RR, but did not influ-
ence the activity of Na
+, K
+-ATPase and the levels of ATP and PCr. We demon-
strated that PBN effectively reduced brain cell membrane lipid peroxidation, but
did not reverse ongoing brain cell membrane dysfunction nor did restore brain cel-
lular energy depletion, in our piglet model of global hypoxic-ischemic brain injury.
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crosses the blood-brain barrier, and penetrates well into the
cell membranes (20, 21). These features make PBN an attrac-
tive therapeutic agent to ameliorate the brain damage from
hypoxic-ischemic brain injury.
However, there are few reports about the effect of PBN on
global hypoxic-ischemic injury in developing brain (22). This
study was done to determine whether free radicals mediate
brain injury during hypoxia-ischemia and reoxygenation-
reperfusion, and whether the brain injury is attenuated by
PBN in newborn piglets. We tested the hypothesis that PBN
attenuates brain damage by scavenging free radicals during
hypoxia-ischemia and reoxygenation-reperfusion of perina-
tal asphyxia. In this study, we used the newborn piglets as
an animal model of perinatal hypoxic-ischemic brain injury
because the piglet brain is comparable in growth velocity to
human brain at birth. Changes in brain cell membrane struc-
ture, function, and energy stores during hypoxia-ischemia
and reoxygenation-reperfusion were determined by measur-
ing lipid peroxidation products (conjugated dienes), Na+,
K+-ATPase activity, and concentration of high-energy phos-
phate compounds in the cerebral cortex, respectively.
MATERIALS AND METHODS
Animal preparation and surgical procedures
The experimental protocols described herein were reviewed
and approved by the Institutional Animal Care and Use Com-
mittee of the Samsung Biomedical Research Center, Seoul,
Korea. This study also followed the institutional and Nation-
al Institutes of Health guidelines for laboratory animal care.
Newborn piglets less than 3 days old and of mixed strain
(Yorkshire, conventional breed, purchased from Paju farm,
Paju, Kyonggi-Do, Korea) were used in this study. Animals
inhaled ether for sedation, and anesthesia was induced with
thiopental sodium (5 mg/kg, i.v.), and supplemental doses
were given when necessary to maintain anesthesia. After local
injection with lidocaine (1%), a tracheostomy was performed
and the piglet was paralyzed with pancuronium (0.1 mg/kg,
i.v.) and ventilated with neonatal pressure-limited, time-cycled
mechanical ventilator (Sechrist Infant Ventilator, IV-100 V,
Sechrist Industries, Anaheim, CA, U.S.A.). Ventilator set-
tings were adjusted to keep the arterial partial oxygen pres-
sure at 80-150 mmHg and the arterial partial carbon dioxide
pressure at 35-45 mmHg. Femoral artery and vein were can-
nulated for monitoring blood pressure, blood sampling, and
for medication and fluid infusion. Bilateral common carotid
arteries were isolated at the level of the fourth cervical vertebral
level and encircled with silk surgical thread (size 4). Through-
out the experiment, the piglet was placed under the servo-
controlled warmer (Airshields, Hatboro, PA, U.S.A.), and
rectal temperature was maintained between 38.0 and 39.0℃.
Experimental protocol
Fifty-one newborn piglets were divided randomly into the
following four experimental groups: nine in the sham opera-
tion control group (C); 13 in the hypoxia-ischemia with vehi-
cle group (HI-C); 10 in the hypoxia-ischemia with PBN
group (HI-PBN); 9 in the reoxygenation-reperfusion with
vehicle group (RR-C); and 10 in the reoxygenation-reperfu-
sion with PBN group (RR-PBN). 
The experimental protocols for each group are described
in Fig. 1. The total duration of each experimental treatment
was 1.5 hr after obtaining stabilization. After surgery and
stabilization, all animals were ventilated to maintain normal
blood gas levels. In C group, normoxic ventilation was main-
tained for 1.5 hr. In hypoxia-ischemia groups (HI-C, HI-
PBN), acute global cerebral hypoxia-ischemia was induced
by temporary but complete occlusion of bilateral common
carotid arteries with surgical clips and simultaneous breath-
ing with 8% oxygen for 30 min. In reoxygenation-reperfu-
sion groups (RR-C, RR-PBN), acute global hypoxia-ischemia
was induced with the same method as in hypoxia-ischemia
groups, and after then, the carotid artery occluders were re-
leased, inspired oxygen concentration was increased to main-
tain oxygen saturation at 90-95%, and normoxic ventilation
was continued for one hour. 
In PBN treatment groups (HI-PBN, RR-PBN), 100 mg/
kg of PBN (Sigma Chemical CO., St. Louis, MO, U.S.A.) in
normal saline (10 mg/mL) was given as a bolus intravenous
injection just before the induction of hypoxia-ischemia (HI-
PBN) and reoxygenation-reperfusion (RR-PBN), respective-
Fig. 1. Experimental protocol.
HI, Hypoxia-ischemia; RR, reoxygenation-reperfusion; PBN,  -
Phenyl-N-tert-Butyl Nitrone (100 mg/kg, i.v.).
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HI+RR+PBN (n=10)ly. In PBN control groups (HI-C, RR-C), vehicle (saline) was
given in the same way as in PBN treatment groups. Heart
rate, oxygen saturation and blood pressure were monitored
continuously during the experiment using the Hewlett-Pac-
kard neonatal monitoring system (Hewlett-Packard Model
M1276A, MA, U.S.A.). Arterial blood gases and concentra-
tions of glucose and lactate in the blood were measured at
baseline, the end of hypoxia-ischemia, and every 30 min after
hypoxia-ischemia.
At the end of each experiment, whole brain tissue was har-
vested immediately using guillotine, frozen rapidly in liquid
nitrogen, and stored at -80℃ for further biochemical analy-
sis. Arterial blood gases were measured on a blood gas ana-
lyzer (Ciba-Corning) and concentrations of glucose and lac-
tate were measured using a YSI model 2300 dual analyzer
(Yellow Springs Instrument Co., Yellow Springs, OH, U.S.A).
Biochemical analyses of brain cortex
Methods of brain cell membrane preparation and determi-
nation of cerebral cortical cell membrane Na+, K+-ATPase
activity, levels of conjugated dienes, tissue glucose and lac-
tate concentrations, ATP and phosphocreatine were described
in detail previously (30). Briefly, brain cell membranes were
prepared according to the method described by Harik et al.
The activity of Na+, K+-ATPase was determined by subtract-
ing the enzyme activity in the presence of ouabain from the
total activity in the absence of ouabain. The level of conju-
gated dienes was determined using the method of Recknagel
and Glende. The concentrations of glucose and lactate in the
cerebral cortex were determined spectrophotometrically using
a commercial kit (Sigma Chemical Co., St. Louis, MO, U.S.A.).
Brain ATP and phosphocreatine levels were determined with
a coupled enzyme assay using the method of Lamprecht et al.
Statistical analysis
Data were analyzed by one-way ANOVA or Kruskal-Wallis
test for intergroup comparisons. To detect significant changes
over time within each group and between groups, data were
compared using repeated measures ANOVA with Bonferroni
post-hoc-test. Statistical analyses described above were done
using SPSS version 11.5. A p-value of <0.05 was considered
significant. Data were given as mean±standard error.
RESULTS
Physiologic variables
After hypoxia-ischemia was induced, heart rate significant-
ly increased, and mean arterial blood pressure significantly
decreased. During reoxygenation-reperfusion, mean arterial
blood pressure returned to near its pre-hypoxia-ischemia level,
while heart rate remained at as high levels as during hypox-
ia-ischemia. Arterial pH, base excess, and PaO2 significant-
ly decreased during hypoxia-ischemia. During reoxygena-
tion-reperfusion, PaO2 recovered to its pre-hypoxia-ischemia
level, while arterial pH and base excess remained at as low
levels as during hypoxia-ischemia. PaCO2 did not change
significantly throughout the experiment. The concentrations
of glucose and lactate in the blood both significantly increased
after hypoxia-ischemia was induced, and then they did not
change significantly to the end of one hour of reoxygenation-
reperfusion (Table 1). 
PBN did not influence above physiologic variables dur-
ing hypoxia-ischemia and during reoxygenation-reperfusion
(Table 1).
Biochemical data in brain cortex
After hypoxia-ischemia was induced, brain lactate level
significantly increased, and recovered halfway during reoxy-
genation-reperfusion, while brain glucose level did not change
significantly all through the experiment. The brain cortical
tissue level of lipid peroxidation products (conjugated dienes),
measured as an indicator of alterations in cell membrane struc-
ture significantly increased during hypoxia-ischemia, and
remained elevated during reoxygenation-reperfusion. Na+,
K+-ATPase activity in the cerebral cortical cell membrane,
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HI, hypoxia-ischemia; RR, reoxygeanation and reperfusion for 1 hr after hypoxia-ischemia; *p<0.05 versus control group.
HI group (n=23) RR group (n=19)
HI-C (n=13) HI-PBN (n=10) RR-C (n=9) RR-PBN (n=10)
Control group (n=9) Physiologic variables
Heart rate (bpm) 187±28 232±46* 241±50* 224±35 238±23*
Mean arterial pressure (mmHg) 70±14 37±15* 42±14* 76±14 64±11
Arterial pH 7.39±0.15 7.23±0.04* 7.23±0.10* 7.25±0.16* 7.24±0.10*
PaO2 (mmHg) 134±62 21±8* 22±3* 127±39 122±28
PaCO2 (mmHg) 38±16 38±12 36±64 4 ±74 1 ±7
Base deficit (mmol/kg) 1.3±4.7 -7.6±2.8* -7.5±5.5* -7.0±6.9* -6.9±5.7*
Blood glucose (mg/dL) 89±21 126±39* 131±24* 114±31 134±24*
Blood lactate (mmol/L) 2.7±0.7 8.5±4.2* 6.1±3.1* 4.9±4.2* 5.6±2.4*
Table 1. Physiologic values and blood glucose and lactate levels of newborn piglets in each experimental group416 C.W. Choi, J.H. Hwang, Y.S. Chang, et al.
measured as an index of brain cell membrane function and
cerebral ATP and phosphocreatine concentrations, measured
as an index of cellular energy state were both significantly
decreased after hypoxia-ischemia was induced. During reoxy-
genation-reperfusion, cerebral ATP and phosphocreatine con-
centrations recovered to near their pre-hypoxia-ischemia lev-
els, while Na+, K+-ATPase activity remained decreased as
during hypoxia-ischemia (Table 2).
PBN significantly decreased the level of conjugated dienes
both during hypoxia-ischemia (0.99±0.09 vs.1.09±0.10)
and during reoxygenation (0.96±0.10 vs.1.06±0.07). PBN
also decreased brain lactate level markedly during reoxygena-
tion-reperfusion, however the decrease was not statistically
significant. PBN did not make any significant changes in
brain glucose level, Na+, K+-ATPase activity, and ATP and
phosphocreatine concentrations during hypoxia-ischemia
and during reoxygenation-reperfusion (Table 2).
DISCUSSION 
In the present study, the level of lipid peroxidation prod-
ucts (conjugated dienes) in the brain significantly decreased
when newborn piglets were pretreated with PBN not only
during reoxygenation-reperfusion, but also during hypoxia-
ischemia. Because lipid peroxides are products of reactive
oxygen species, this result shows that PBN acted as an effec-
tive free radical scavenger in our piglet model of hypoxia-
ischemia and reoxygenation-reperfusion. Membrane lipid
peroxidation is among the important causes of cell membrane
destruction and cell damage, and is an indicator of the amount
of oxidative stress related to secondary energy failure (5, 6,
24, 25). Secondary energy failure has been known to be asso-
ciated with poor neurodevelopmental outcome (26). There-
fore, it is suggested that PBN may be neuroprotective in
hypoxic-ischemic brain injury.
During hypoxia-ischemia, there is an increase in the lev-
els of reduced forms of the electron transport chain compo-
nents in mitochondria, leading to a production of oxygen
free radicals (27). Other mechanisms contributing reactive
oxygen free radical formation and membrane lipid peroxida-
tion include metabolism of arachidonic acid via the cyclooxy-
genase and lipoxygenase pathways, reactions catalyzed by
increased free intracellular Fe++, and increased xanthine oxi-
dase activity as a result of increased degradation of ATP (28).
However, the production of oxygen free radicals is much
greater during reoxygenation-reperfusion than during hypox-
ia-ischemia (29). The breakdown of hypoxanthine by xan-
thine oxidase in the presence of oxygen produces a flood of
superoxide radicals (30). Therefore, it may be postulated that
the action of PBN as a free radical scavenger would be greater
during that period. However, our data do not support such
a postulation, because there was no significant difference not
only in the level of conjugated dienes, but also in the effect
of PBN on the level of conjugated dienes between during
hypoxia-ischemia and during reoxygenation-reperfusion. The
reason why there was no significant difference in the level of
conjugated dienes between during hypoxia-ischemia and
during reoxygenation-reperfusion is not clear. However, in a
series of our previous studies with the same piglet model of
hypoxia-ischemia and reoxygenation-reperfusion, there was no
significant difference in the level of conjugated dienes between
during hypoxia-ischemia and during reoxygenation-reper-
fusion, either (23, 31-34). Therefore, it does not seem that
there is a direct dose-response relationship between the amount
of oxidative stress and the level of conjugated dienes in our
piglet model of hypoxia-ischemia and reoxygenation-reper-
fusion.
Na+, K+-ATPase is a membrane-bound, energy-dependent
enzyme, and is critical to normal brain cell function, but sus-
ceptible to disturbance of membrane integrity that may be
induced by lipid peroxidation (35). Therefore, the activity of
Na+, K+-ATPase was selected as a marker of brain cell mem-
brane function in our present study. Our data demonstrated
that the activity of Na+, K+-ATPase decreased in accordance
with the decrease of the concentrations of ATP and phospho-
creatine during hypoxia-ischemia. However, during reoxy-
genation-reperfusion, even if the concentration of ATP has
recovered to near sham operation control value, the activity
of Na+, K+-ATPase still remained at the level as low as dur-
ing hypoxia-ischemia. This finding is consistent with that
of Resenkrantz et al. (36). In their study, the activity of Na+,
K+-ATPase was not repaired or restored following recovery
from brain hypoxia even though the oxidative phosphoryla-
HI, hypoxia-ischemia; RR, reoxygeanation and reperfusion for 1 hr after hypoxia-ischemia; *p<0.05 versus control group; 
� p<0.05 versus. vehicle-
treated group.
HI group (n=23) RR group (n=19)
HI-C (n=13) HI-PBN (n=10) RR-C (n=9) RR-PBN (n=10)
Control group (n=9) Biochemical data
Brain glucose ( mol/g proteins) 3.7±1.0 3.0±0.6 3.8±1.6 4.2±2.3 4.9±1.3
Brain lactate ( mol/g proteins) 3.3±1.1 15.3±5.3* 15.6±6.2* 6.4±8.0 3.2±0.6
Conjugated dienes ( mol/g protein) 0.82±0.07 1.09±0.10* 0.99±0.09*
� 1.06±0.07* 0.96±0.10*
�
Na
+, K
+-ATPase activity ( mol Pi/mg protein/hr) 53.6±2.8 45.9±7.6* 42.6±2.0* 45.7±1.5* 48.5±0.8*
ATP (mmol/kg) 3.3±0.8 2.0±1.0* 1.7±1.1* 3.1±0.6 3.4±0.8
Phosphocreatine (mmol/kg) 3.7±0.8 2.0±0.6* 1.5±0.5* 3.0±0.7* 3.2±0.7
Table 2. Biochemical data in cerebral cortex of newborn piglets in each experimental group-Phenyl-N-tert-Butyl Nitrone (PBN) and Hypoxic-ischemic Brain Injury 417
tion was normalized. The activity of Na+, K+-ATPase is de-
pendent on the cellular energy state, because ATP is rquired
as substrate for the enzyme. During hypoxia-ischemia, there
is a reduced production of ATP, which may lead to a decrease
in Na+, K+-ATPase activity (37). It has also been known that
oxygen-containing free radicals produce permanent inhibition
of Na+, K+-ATPase, probably via lipid peroxidation during
ischemia (38). Both data of ours and Rosenkrantz et al. impli-
cate that the lack of recovery of the enzyme may be due to
severe lipid peroxidation of the normal neuronal membrane
and not a failure of oxidative phosphorylation. Moreover, in
our study, even though PBN reduced the level of conjugated
dienes significantly both during hypoxia-ischemia and during
reoxygenation-reperfusion, it failed to recover the activity of
Na+, K+-ATPase during reoxygenation-reperfusion. This
finding suggests that there may be an ongoing cell membrane
dysfunction despite successful free radical scavenging by PBN
during reoxygenation-reperfusion. However, the activity of
Na+, K+-ATPase may also be reduced by other factors than
oxygen free radicals such as the accumulation of fatty acid-
related inhibitors of the enzyme (e.g. arachidonic acid, other
long-chain fatty acids, lysophospholipids, and prostaglandins),
the hydrolysis of cell membrane phospholipid which is requir-
ed for activity of the enzyme, and calcium influx following
activation of glutamate receptors in hypoxic-ischemic brain
injury (39). The lack of recovery of Na+, K+-ATPase activity
may be in part attributable to these factors.
It has been known that after initial recovery of energy state
during reoxygenation-reperfusion, secondary energy failure
ensues a few hours later (40). Mechanisms involved in the
evolution of secondary cerebral energy failure are not clear,
but its delayed onset and gradual progression suggest a pro-
cess triggered by the primary insult, possibly related to exci-
totoxicity, oxygen free radicals, or cytokine release (24, 25).
Clinical investigations have shown that the prognosis of sec-
ondary cerebral energy failure was grave and extent of delayed
energy failure was related to the severity of later neurodevel-
opmental impairment (26). It may be expected that PBN
attenuates secondary energy failure, leading to improved neu-
rodevelomental prognosis, by scavenging oxygen free radi-
cals during early reoxygenation-reperfusion period. In our
present study, however, PBN did not affect cellular energy
metabolism both during hypoxia-ischemia and during reoxy-
genation-reperfusion. In our previous study with the same
piglet model of transient global cerebral hypoxia-ischemia,
secondary energy failure was observed from 24 hr later on
(31). Therefore, our experiment protocol that allowed only
an hour of reoxygenation-reperfusion may be too short to
evaluate the effect of PBN on cellular energy metabolism
properly. Indeed, Nakai et al., in their rat model of intrauter-
ine ischemia and reperfusion, reported that delayed treatment
of PBN (after one hour of recirculation) significantly improved
cellular energy state after four hours of recirculation (22). Fur-
ther study that allows more prolonged duration of reoxygena-
tion-reperfusion may be needed to evaluate the effect of PBN
on brain energy metabolism properly.
In our piglet model of global hypoxic-ischemic brain injury,
we demonstrated that there was an increase in brain cell mem-
brane lipid peroxidation, which was successfully reduced with
PBN both during hypoxia-ischemia and during reoxygena-
tion-reperfusion. However, ongoing brain cell membrane
dysfunction was not reversed, and brain cellular energy deple-
tion was not restored, by PBN.
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